Ensituximab

Ensituximab
Monoclonal antibody
Type Whole antibody
Source Chimeric (mouse/human)
Target 5AC
Clinical data
ATC code none
Identifiers
CAS Number 1092658-06-4 N
ChemSpider none
UNII F988K568V2 YesY
Chemical and physical data
Formula C6342H9800N1678O1985S46
Molar mass 142.8 kg/mol
 NYesY (what is this?)  (verify)

Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.[1]

Ensituximab was developed by Neogenix Oncology, Inc.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Ensituximab" (PDF). American Medical Association.


This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.